SGK1 and Cerebral ischemia: In hypoxic-ischemic brain injury, short-chain fatty acids were validated to inhibit inflammation produced by cerebral ischemia by reducing astrocyte activation through the SGK1/IL-6 signaling pathway (Gao et al., 2022).